ABSTRACT
Which a Particular Brand of Medicine Remains Protable ..................................... 497 22.5.4 To Enable the Drug to Be Used for New Indications ............................................... 497 22.5.5 To Enable Use in Specialist Populations or to Facilitate Prescription to OTC
Switches .................................................................................................................... 497 22.5.6 To Create and Exploit Intellectual Property and Other Barriers to Market Entry
by Competitors (Especially Generics) ...................................................................... 498 22.5.6.1 Patents ........................................................................................................ 498 22.5.6.2 Market Exclusivity ..................................................................................... 498 22.5.6.3 Technical and Investment Barriers ............................................................500
